U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of Policy, Legislation, and International Affairs
  6. Office of Economics and Analysis
  1. Office of Policy, Legislation, and International Affairs

Office of Economics and Analysis

Beethika Khan, Ph.D., Associate Commissioner for Economics and Analysis

Mission

The Office of Economics and Analysis (OEA) provides public health, economic, and strategic analysis and evaluation to inform FDA’s policy and rulemaking decisions.

Major Functions

OEA advises and assists the Commissioner and senior leadership on the public health, social science, and economic implications of Agency programs, priorities, and initiatives. 

We conduct economic, public health, social science, and operations research as a basis for analyzing and forecasting trends, needs, and major problems requiring solutions. We also provide assistance and consultation in these areas to FDA leadership and operating units. We evaluate impacts of external factors on Agency programs, including industry market dynamics, consumer expectations, and prospective legislation. OEA develops regulatory impact analysis for FDA’s rulemaking. OEA also leads the Agency’s engagement in GAO and OIG studies through timely clearance and transmission of requested information. 

Office Divisions and Contact

OEA is led by the Associate Commissioner for Economics and Analysis and consists of two components: The Economics Staff and the Public Health Strategy and Analysis (PHSA) Staff which includes the Public Health Initiatives Team and the GAO/OIG Liaison Team.

Associate Commissioner for Economics and Analysis: 
Beethika Khan 
Email: Beethika.Khan@fda.hhs.gov 

Economics Staff: 
Ephraim Leibtag, Chief Economist
Email: Ephraim.Leibtag@fda.hhs.gov 

PHSA Staff: 
Harinder Chahal, Staff Director 
Email: Harinder.Chahal@fda.hhs.gov 

GAO/OIG Liaison Team: 
Claudia Grillo, Team Lead 
Email: Claudia.Grillo@fda.hhs.gov 

Quick Links & Resources



Contact Us

Contact Point
FDA/OC/OPLIA/Office of Economics and Analysis
10903 New Hampshire Ave
Silver Spring, MD 20993
Hours Available
FDA_OEA@fda.hhs.gov
Back to Top